0 Comentários
0 Compartilhamentos
2KB Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Cancer Immunotherapy Market Dynamics: Drivers, Restraints, Opportunities, and ChallengesThe Cancer Immunotherapy Market is witnessing substantial growth as healthcare systems worldwide increasingly adopt innovative cancer treatment approaches. Immunotherapy has emerged as one of the most promising therapeutic solutions in oncology, offering improved survival rates and targeted treatment options for patients suffering from various forms of cancer. The growing prevalence of cancer,...0 Comentários 0 Compartilhamentos 505 Visualizações 0 Anterior
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Comentários 0 Compartilhamentos 464 Visualizações 0 Anterior
-
Expanding Immunotherapy Use Boosts US Non-Small Cell Lung Cancer Market GrowthThe United States represents the largest contributor to the NSCLC market due to its extensive oncology care network, strong clinical research ecosystem, and high healthcare expenditure. The country continues to witness significant advancements in targeted therapies aimed at specific genetic mutations such as EGFR, ALK, ROS1, and KRAS. Increased utilization of immunotherapy drugs and combination...0 Comentários 0 Compartilhamentos 296 Visualizações 0 Anterior
-
Pioneering Therapeutic Frontiers: Cancer Immunotherapy Market Growth, Opportunities, and Strategic Analysis by 2031The Cancer Immunotherapy Market is at the forefront of revolutionizing cancer care, offering transformative treatment options that harness the body’s immune system to combat malignancies more effectively. According to industry projections, the Cancer Immunotherapy Market size is expected to reach US$ 319,946 million by 2031, with the market anticipated to register a compound annual growth...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Revealed: Asia Pacific Cancer Immunotherapy Market Share Set to Expand Rapidly in the Coming YearsThe landscape of the Asia Pacific Cancer Immunotherapy Market is poised for transformative growth, with expectations for significant expansion in market share. As of 2024, the market size is estimated at $130.18 million, set to grow to an impressive $463.26 million by 2035, reflecting a remarkable compound annual growth rate (CAGR) of 12.23%. This rapid ascent signals not only a robust demand...0 Comentários 0 Compartilhamentos 156 Visualizações 0 Anterior
-
Self-Amplifying RNA Cancer Immunotherapy Platforms Market Growth, Analysis with Impact of COVID-19 top Companies, Trends, Future Opportunity Analysis By FMINEWARK, DE | The Self-Amplifying RNA Cancer Immunotherapy Platforms Market was valued at USD 94.0 million in 2025 and is expected to reach USD 112.0 million in 2026. Expanding at a CAGR of 19.10%, the market is projected to achieve USD 643.2 million by 2036. This growth reflects a critical shift in oncology toward dose-sparing RNA technologies that address systemic toxicity...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Cytokine Market Future Outlook and Investment OpportunitiesThe growing focus on immunology, targeted therapies, and advanced biologics is significantly driving the expansion of the cytokine industry worldwide. Cytokines play a vital role in regulating immune responses, inflammation, and cell signaling, making them essential in the treatment of cancer, autoimmune disorders, infectious diseases, and inflammatory conditions. Increasing investments in...0 Comentários 0 Compartilhamentos 701 Visualizações 0 Anterior
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior1
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior1
-
Intravesical Bacillus Calmette Market Trends in Oncology and Urology CareThe global intravesical Bacillus Calmette market is experiencing significant growth due to the increasing prevalence of bladder cancer and the rising adoption of immunotherapy-based treatment approaches. Intravesical Bacillus Calmette therapy has become one of the most widely used treatment options for non-muscle invasive bladder cancer (NMIBC), offering effective recurrence prevention and...0 Comentários 0 Compartilhamentos 687 Visualizações 0 Anterior
-
Market Outlook 2025–2031: Future of Sarcoma Drug DevelopmentOrphan drug designation is supporting market expansion.Regulatory incentives encourage rare cancer drug development.Faster approvals enhance product commercialization opportunities The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 Comentários 0 Compartilhamentos 8KB Visualizações 0 Anterior1
-
Neoantigens Market Growth Accelerating Toward US$ 5,607.32 Million by 2034Neoantigens are mutation-driven epitopes that emerge from genetic instability within cancer cells, creating novel targets not found in normal human tissues. Because they are entirely tumor-specific, they bypass central immune tolerance and can provoke strong, selective immune responses. This distinct biological property positions neoantigens at the forefront of precision immuno-oncology and...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Prostate Cancer Vaccines Market Industry Trends & OpportunitiesThe Prostate Cancer Vaccines Market is gaining strong momentum as the global healthcare industry intensifies its focus on precision oncology, immunotherapy, and preventive cancer care. According to industry analysis, the market is projected to grow from US$ 1.51 billion in 2025 to US$ 3.48 billion by 2034, registering a CAGR of 10.97% during 2026–2034. Increasing incidence of prostate...0 Comentários 0 Compartilhamentos 463 Visualizações 0 Anterior
Páginas impulsionada